Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Endocrinology

Management and Treatment Strategies for SLOS

At a Glance

Management of Smith-Lemli-Opitz Syndrome (SLOS) focuses on dietary and medical cholesterol supplementation to support development and reduce toxic 7-DHC buildup. Care also requires an emergency "sick-day" steroid plan for adrenal insufficiency and strict sun protection.

While there is currently no cure for Smith-Lemli-Opitz Syndrome (SLOS), modern medical care focuses on managing symptoms, preventing emergencies, and improving quality of life. Treatment is highly personalized, requiring a team of specialists to manage the complex metabolic needs of the body [1][2].

Emergency Planning: The “Sick-Day” Protocol

Before discussing daily management, it is crucial to address the most severe acute risk: Adrenal Insufficiency.
Because the body uses cholesterol to make stress hormones (like cortisol), individuals with SLOS may not produce enough hormones to handle acute stress, illness, or surgery [3]. This can lead to an adrenal crisis, which is a life-threatening emergency.

  • Actionable Step: You must work with an endocrinologist to create a “sick-day plan” [3]. This plan dictates when and how to administer emergency stress dose steroids (like hydrocortisone) during illnesses or physical trauma.

The Foundation: Cholesterol Supplementation

The primary goal of daily treatment is to address the lack of cholesterol and the buildup of toxic precursors like 7-DHC [4].

Why Supplement?

By providing the body with extra cholesterol, doctors aim to:

  1. Increase Cholesterol Levels: Providing the building blocks needed for brain development, hormone production, and cell health [5][6].
  2. Suppress 7-DHC Production: When the body senses it has enough cholesterol, it naturally slows down its own faulty production line, which helps lower the toxic buildup of the 7-DHC precursor [5].

How is it Done?

Cholesterol can be supplemented through diet or medical-grade products:

  • Natural Sources: Egg yolks are a rich source of cholesterol [7]. Safety Note: Because raw or undercooked eggs carry a risk of foodborne illness, always consult a metabolic dietitian on how to safely prepare and dose dietary egg yolks.
  • Medical-Grade Supplements & Formulas: Doctors may prescribe pharmaceutical-grade cholesterol powder. Additionally, some individuals require specialized medical formulas because they cannot tolerate standard fats or need highly specific fat-to-cholesterol ratios [5].
  • Feeding Support: Many individuals with SLOS use a gastrostomy tube (G-tube) to ensure consistent and stress-free intake of supplements [8].

Adjunctive and Investigational Therapies

Doctors may also prescribe medications “off-label” (using an approved drug for an unapproved use) or through clinical trials to balance body chemistry.

Simvastatin: A Counter-Intuitive Approach

Statins are famous for lowering cholesterol in the general public, which makes prescribing them to a cholesterol-deficient SLOS patient seem alarming. However, the mechanism makes sense when understood:

  • The Mechanism: Simvastatin blocks the body’s cholesterol production pathway very early on (upstream). By shutting down the factory early, the body is prevented from creating the toxic 7-DHC precursor that causes damage [9].
  • Behavioral Benefits: Because it crosses the blood-brain barrier, studies show simvastatin can significantly reduce irritability and “meltdowns” in some individuals with SLOS [9].

Cholic Acid

Cholic acid is a type of bile acid. Children with SLOS cannot make enough natural bile acids because bile is synthesized from cholesterol [10].

  • The Mechanism: Without bile acids, the digestive system cannot actually absorb the dietary cholesterol and fat-soluble vitamins (like Vitamin E) they are being given. Supplementing cholic acid helps the gut absorb these vital nutrients and may increase plasma cholesterol levels [11][12]. Ask your doctor about the current regulatory or clinical trial status of cholic acid for SLOS.

Comprehensive Management

  • Vitamin Supplementation: Vitamin E is often recommended as an antioxidant to protect cells from the stress caused by high 7-DHC levels [7].
  • Sun Protection: Due to 7-DHC buildup, there is a high risk of extreme sensitivity to sunlight (photosensitivity). High-SPF sunscreen and protective clothing are essential daily requirements [7].

Common questions in this guide

Why do patients with SLOS need cholesterol supplements?
Patients with SLOS cannot produce enough cholesterol naturally. Supplementing cholesterol provides essential building blocks for brain development and helps stop the body from producing toxic byproducts like 7-DHC.
What is a sick-day plan for SLOS?
A sick-day plan is an emergency protocol created with an endocrinologist for times of physical stress, illness, or surgery. It provides instructions on when and how to give stress dose steroids to prevent a life-threatening adrenal crisis.
Why is simvastatin prescribed for Smith-Lemli-Opitz syndrome?
While normally used to lower cholesterol, simvastatin blocks the faulty cholesterol production pathway early on. This stops the buildup of a toxic precursor called 7-DHC and can help reduce severe behavioral issues and irritability.
How does sun sensitivity affect individuals with SLOS?
The toxic buildup of 7-DHC in the skin causes extreme sensitivity to sunlight, known as photosensitivity. Daily sun protection, including high-SPF sunscreen and protective clothing, is essential to prevent severe skin damage.
What is the role of cholic acid in SLOS treatment?
Children with SLOS often lack natural bile acids, making it hard for their bodies to digest and absorb dietary cholesterol and fat-soluble vitamins. Cholic acid supplementation helps the gut absorb these vital nutrients effectively.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the target cholesterol level, and how often will we test the blood to monitor it?
  2. 2.Can we meet with a metabolic dietitian to create a safe plan for dietary cholesterol, including proper preparation to avoid foodborne illness?
  3. 3.Is simvastatin a viable off-label option to help with irritability, and how does the mechanism work in this specific case?
  4. 4.Given the potential for fat-absorption issues, should we consider cholic acid therapy, and is it available outside of a clinical trial?
  5. 5.What is our emergency 'sick-day plan' if signs of an adrenal crisis occur?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    First documented case of Smith-Lemli-Opitz syndrome in Syria: clinical presentation, diagnosis, and experimental management with simvastatin.

    Aladia AH, Hamdan S, Alkheder A

    Oxford medical case reports 2024; (2024(11)):omae129 doi:10.1093/omcr/omae129.

    PMID: 39575090
  2. 2

    Smith-Lemli-Opitz syndrome: Clinical, biochemical, and genetic insights with emerging treatment opportunities.

    Kritzer A, Dutta R, Pramparo T, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2025; (27(7)):101450 doi:10.1016/j.gim.2025.101450.

    PMID: 40314187
  3. 3

    Smith-Lemli-Opitz syndrome: clinical and biochemical correlates.

    Donoghue SE, Pitt JJ, Boneh A, White SM

    Journal of pediatric endocrinology & metabolism : JPEM 2018; (31(4)):451-459 doi:10.1515/jpem-2017-0501.

    PMID: 29455191
  4. 4

    The role of cholesterol biosynthesis and metabolism causing medical complexity in patients with Smith-Lemli-Opitz Syndrome (SLOS).

    Elias ER

    The Journal of steroid biochemistry and molecular biology 2025; (254()):106822 doi:10.1016/j.jsbmb.2025.106822.

    PMID: 40609800
  5. 5

    The Smith-Lemli-Opitz syndrome and dentofacial anomalies diagnostic: Case reports and literature review.

    Rojare C, Opdenakker Y, Laborde A, et al.

    International orthodontics 2019; (17(2)):375-383 doi:10.1016/j.ortho.2019.03.020.

    PMID: 31005410
  6. 6

    Smith-Lemli-Opitz Syndrome (SLOS)-Case Description and the Impact of Therapeutic Interventions on Psychomotor Development.

    Kozera N, Śmigiel R, Rozensztrauch A

    Journal of clinical medicine 2025; (14(23)) doi:10.3390/jcm14238569.

    PMID: 41375871
  7. 7

    Biochemical and Clinical Effects of Vitamin E Supplementation in Hungarian Smith-Lemli-Opitz Syndrome Patients.

    Koczok K, Horváth L, Korade Z, et al.

    Biomolecules 2021; (11(8)) doi:10.3390/biom11081228.

    PMID: 34439893
  8. 8

    A Case of Smith-Lemli-Opitz Syndrome Diagnosed with Hypertrophic Pyloric Stenosis.

    Eren EE, Bilgin N, Urganci N, Kose G

    Sisli Etfal Hastanesi tip bulteni 2021; (55(2)):268-271 doi:10.14744/SEMB.2020.34651.

    PMID: 34349606
  9. 9

    A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome.

    Wassif CA, Kratz L, Sparks SE, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(3)):297-305 doi:10.1038/gim.2016.102.

    PMID: 27513191
  10. 10

    Long-Term Cholic Acid Treatment in a Patient with Zellweger Spectrum Disorder.

    Heubi JE, Bishop WP

    Case reports in gastroenterology 2018; (12(3)):661-670 doi:10.1159/000494555.

    PMID: 30519152
  11. 11

    Use of cholic acid in Smith-Lemli-Opitz syndrome (SLOS): real-world patient outcomes.

    Ferren E, Hillman PR, Kritzer A, et al.

    Orphanet journal of rare diseases 2025; (20(1)):381 doi:10.1186/s13023-025-03914-x.

    PMID: 40722188
  12. 12

    Cholic acid increases plasma cholesterol in Smith-Lemli-Opitz syndrome: A pilot study.

    Elias ER, Orth LE, Li A, et al.

    Molecular genetics and metabolism reports 2024; (38()):101030 doi:10.1016/j.ymgmr.2023.101030.

    PMID: 38077958

This page provides educational information about SLOS management strategies. Always consult a metabolic specialist or endocrinologist before altering a patient's diet, medications, or emergency care plans.

Get notified when new evidence is published on Smith-Lemli-Opitz syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.